MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2025 International Congress

October 5-9, 2025. Honolulu, Hawaii.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Utilization of Healthcare and Deep Brain Stimulation in Black and White Patients with Parkinson’s Disease

    M. Padmanaban, C. Liao, J. Johnson, K. Booker, M. Rizig, W. Abou Chaar, J. Bundy, H. Leeper, P. Warnke, B. Chiu, T. Xie (Chicago, USA)

  • Utilization of Phosphorylated Alpha-Synuclein Skin Biopsy Testing in a Movement Disorders Center

    S. Anis, A. Kundrick, C. Piccinin, T. Lopez-Gonzalez, D. Dos Santos, H. Fernandez (Cleveland, USA)

  • Utilizing the 15-item modification of the PSPRS rating scale (mPSPRS-15) as the primary endpoint for future clinical trials in progressive supranuclear palsy

    F. Nery, T. Nevmyrych, J. Murphy, S. Wu, Y. Zabar, A. Gafson, S. Bullain, J. O’Gorman (Cambridge, USA)

  • Utilizing the Global Parkinson’s Genetics Program (GP2) to develop a precision medicine recruitment protocol

    K. Atterling Brolin, YY. Beh, P. Saffie Awad, J. Aviles, A. Pajo, E. Navarro-Jones, C. Klein, I. F. Mata, K. Paquette, H. Iwaki, L. Jones, H. Leonard, N. Okubadejo, C. Blauwendraat, L. Screven, A. Noyce, M. Toffoli, AH. Tan, H. Morris, M. Nalls (Lund, Sweden)

  • Utilizing the Levodopa Challenge Test to Clarify Clinical Complaints Following Levodopa Administration: A Case Series

    M. da Silva, C. Ternes, B. de Lima, R. Mesquita, L. Moriyama (Campinas, Brazil)

  • Utilizing Virtual Reality in Educational Programs for Parkinson’s Disease Rehabilitation: A Review of Current Literature and Future Directions

    S. A. Hassan, Y. Mohamed, M. Abouelseoud, A. Alaa, A. Hafez, M. M. Elsayed (Giza, Egypt)

  • Vagus nerve ultrasound and its association with non-motor symptoms in parkinson’s disease

    S. Garcia, J. Sanchez, J. Grandas (MADRID, Spain)

  • Valbenazine Improves Chorea Across Multiple Body Regions in Adults With Huntington’s Disease

    E. Furr Stimming, E. Kayson, R. Mehanna, J. Goldstein, S. Hinton, O. Klepitskaya, H. Zhang, D. Haubenberger (Houston, USA)

  • Valbenazine Improves the Burden and Symptoms of Tardive Dyskinesia: Topline Results from the Phase 4 KINECT-PRO Study

    E. Dunayevich, A. Parameswaran, M. Bron, E. Franey, D. Sparta, C. Zeng, S. Mathias, J. Mcevoy (San Diego, USA)

  • Validating Real-World Evidence for Identifying Adverse Events Related to a Deep Brain Stimulation Implant

    J. Joseph, Y. Pathak, C. Salazar, A. Benison (Plano, USA)

  • « Previous Page
  • 1
  • …
  • 174
  • 175
  • 176
  • 177
  • 178
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Month
  • All Time
    • Effect of marijuana on Essential Tremor: A case report
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley